SLC35D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.386600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.326400E-01
Normal-vs-Stage2
4.168800E-01
Normal-vs-Stage3
9.983800E-01
Normal-vs-Stage4
1.827850E-01
Stage1-vs-Stage2
9.978000E-01
Stage1-vs-Stage3
5.054200E-01
Stage1-vs-Stage4
3.010200E-01
Stage2-vs-Stage3
3.523200E-01
Stage2-vs-Stage4
7.224200E-02
Stage3-vs-Stage4
1.485820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.676000E-01
Normal-vs-AfricanAmerican
1.242020E-01
Normal-vs-Asian
6.009400E-01
Caucasian-vs-AfricanAmerican
1.644800E-01
Caucasian-vs-Asian
7.142800E-01
AfricanAmerican-vs-Asian
1.650030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.445000E-01
Normal-vs-Female
4.514400E-01
Male-vs-Female
7.957800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.267600E-01
Normal-vs-Age(41-60Yrs)
2.709000E-01
Normal-vs-Age(61-80Yrs)
5.382800E-01
Normal-vs-Age(81-100Yrs)
7.078600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.976200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.889200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.763400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.706400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.944180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.570800E-01
Normal-vs-Daily Drinker
6.688000E-01
Normal-vs-Weekly Drinker
6.023800E-01
Normal-vs-Occasional Drinker
5.786000E-01
Normal-vs-Social Drinker
4.405400E-01
Non Drinker-vs-Daily Drinker
9.866000E-01
Non Drinker-vs-Weekly Drinker
7.764400E-01
Non Drinker-vs-Occasional Drinker
8.841400E-01
Non Drinker-vs-Social Drinker
3.725200E-01
Daily Drinker-vs-Weekly Drinker
8.384600E-01
Daily Drinker-vs-Occasional Drinker
8.972800E-01
Daily Drinker-vs-Social Drinker
3.908600E-01
Weekly Drinker-vs-Occasional Drinker
7.175600E-01
Weekly Drinker-vs-Social Drinker
2.963200E-01
Occasional Drinker-vs-Social Drinker
4.513200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.811420E-01
Normal-vs-Grade 2
7.652500E-02
Normal-vs-Grade 3
7.477600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.189380E-01
Grade 1-vs-Grade 3
1.348960E-01
Grade 1-vs-Grade 4
1.811420E-01
Grade 2-vs-Grade 3
9.131600E-01
Grade 2-vs-Grade 4
7.652500E-02
Grade 3-vs-Grade 4
7.477600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.117200E-01
Normal-vs-NonDiabetic
5.061800E-01
Diabetic-vs-NonDiabetic
7.687400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.081200E-01
Normal-vs-NoPancreatitis
5.127400E-01
Pancreatitis-vs-NoPancreatitis
6.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.196200E-01
Normal-vs-N1
3.915600E-01
N0-vs-N1
9.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.107000E-01
Normal-vs-TP53-NonMutant
3.883400E-01
TP53-Mutant-vs-TP53-NonMutant
7.168800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
